Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$287,876
+$37,328 QoQ
Shares Held
1,144
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#3,659
of 4,150 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Napier Financial, LLC holds $1,992,516 across 9 Drug Manufacturers - General names. ABBV ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,473 | $1,136,007 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,144 | $287,876 | |
| 3 | AMGN |
Amgen Inc
|
732 | $265,071 | |
| 4 | PFE |
Pfizer Inc
|
4,452 | $107,204 | |
| 5 | LLY |
ELI LILLY & Co
|
82 | $98,353 | |
| 6 | MRK |
Merck & Co., Inc.
|
625 | $80,312 | |
| 7 | NVS |
Novartis AG
|
74 | $11,597 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
103 | $5,934 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,876 | 1,144 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $250,548 | 1,152 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||